Companies presented data on their drugs, and investors responded by punishing or rewarding shares.
Cabot Oil & Gas is initiated with an 'overweight,' and Merck is downgraded to 'market perform.'
In a bubbly year for the biotech sector, these five stocks stand out over the rest -- some may surprise you.
The FDA should make a speedy review of the breakthrough cancer drug a top priority.
Aeropostale is downgraded to 'neutral,' and Warner Chilcott is upgraded to 'buy.'
Amgen, Celgene and Pharmacyclics see short interest drop recently.
There's mixed interest in biotech, biopharmaceutical and emerging pharma companies.
The classification of ibrutinib as a breakthrough therapy could mean speedy approval by the agency.
VIDEO ON MSN MONEY
Copyright © 2014 Microsoft. All rights reserved.
An interest rate tease in The Wall Street Journal sends the market into an optimistic tizzy -- but one that doesn't end quite at the top.
The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.
MONEY & POLITICS
Breaking up big banks is an untested solution to the too big to fail problem that attempts to isolate and dismantle large, troubled institutions while protecting the rest of the economy.
Some workers lose up to a quarter of their paychecks paying off old debt from credit cards, medical bills and student loans, as well as child support.
Six weeks later, most Americans have forgotten about the 2014 tax season -- except those who didn't file by the April 15 deadline.
MUST-SEE ON MSN
A charcuterie master shares his process for cold-smoking meat at home.
- Jetpacks about to go mainstream
- Weird things covered by home insurance
- Bing: 70 percent of adults report 'digital eye strain'